Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Thrombosis and Haemostasis|July 3, 2019
Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa ActivitySophie Featherby, Yahya Madkhali, Anthony Maraveyas, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2016
Cancer microvesicles induce tissue factor-related procoagulant activity in endothelial cells in vitroMufuliat Adeola Adesanya, Anthony Maraveyas, Leigh A MaddenOnkologie|June 5, 2010
Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinibGeorge Bozas, Anu Roy, Vani Ramasamy, et al.Thrombosis and Haemostasis|November 22, 2013
Filamin-A is required for the incorporation of tissue factor into cell-derived microvesiclesMary E W Collier, Anthony Maraveyas, Camille EttelaieEuropean Journal of Gastroenterology & Hepatology|October 2, 2015
Self-expandable metal stent placement for malignant duodenal obstruction distal to the bulbKeith Wan Hang Chiu, Abdul Razack, Anthony MaraveyasOncology Research and Treatment|January 31, 2015
Retention of platinum sensitivity till late stages of tumour progression may imply improved prognosis of oesophageal and gastric cancersMohan Hingorani, Sanjay Dixit, Rajarshi Roy, et al.Scientific Reports|December 2, 2020
Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activitiesMohammad A Mohammad, John Greenman, Anthony Maraveyas, et al.Biochimica Et Biophysica Acta|May 3, 2002
Reduction of streptavidin RYDS-mediated renal adhesion by site-directed mutagenesisSamuel Murray, Anthony Maraveyas, Tammy Dougan, et al.Cancers|November 12, 2013
The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond ThrombosisHussein Echrish, Leigh A Madden, John Greenman, et al.Anti-Cancer Drugs|January 24, 2006
From total empiricism to a rational design of metronomic chemotherapy phase I dosing trialsThomas Lam, John W Hetherington, John Greenman, et al.Pageof 12